These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30857516)

  • 21. Cellular mechanisms in sepsis.
    Jean-Baptiste E
    J Intensive Care Med; 2007; 22(2):63-72. PubMed ID: 17456726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis.
    Lorente-Sorolla C; Garcia-Gomez A; Català-Moll F; Toledano V; Ciudad L; Avendaño-Ortiz J; Maroun-Eid C; Martín-Quirós A; Martínez-Gallo M; Ruiz-Sanmartín A; Del Campo ÁG; Ferrer-Roca R; Ruiz-Rodriguez JC; Álvarez-Errico D; López-Collazo E; Ballestar E
    Genome Med; 2019 Oct; 11(1):66. PubMed ID: 31665078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could stem cells be the future therapy for sepsis?
    Kingsley SM; Bhat BV
    Blood Rev; 2016 Nov; 30(6):439-452. PubMed ID: 27297212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental Study of the Protective Effect of Simvastatin on Lung Injury in Rats with Sepsis.
    Wang Y; Yang W; Zhao X; Zhang R
    Inflammation; 2018 Feb; 41(1):104-113. PubMed ID: 29022140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.
    Park HJ; Lee SJ; Cho J; Gharbi A; Han HD; Kang TH; Kim Y; Lee Y; Park WS; Jung ID; Park YM
    J Nat Prod; 2018 Jun; 81(6):1435-1443. PubMed ID: 29851490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The leptin system: a potential target for sepsis induced immune suppression.
    Tschöp J; Dattilo JR; Prakash PS; Kasten KR; Tschöp MH; Caldwell CC
    Endocr Metab Immune Disord Drug Targets; 2010 Dec; 10(4):336-47. PubMed ID: 20923403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D3 suppresses immune reactions in atherosclerosis, affecting regulatory T cells and dendritic cell function.
    Bobryshev YV
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2317-9. PubMed ID: 21084698
    [No Abstract]   [Full Text] [Related]  

  • 28. TRAIL encapsulated to polypeptide-crosslinked nanogel exhibits increased anti-inflammatory activities in Klebsiella pneumoniae-induced sepsis treatment.
    Chen YF; Chen GY; Chang CH; Su YC; Chen YC; Jiang YS; Jan JS
    Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():85-95. PubMed ID: 31147057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulinastatin inhibited sepsis-induced spinal inflammation to alleviate peripheral neuromuscular dysfunction in an experimental rat model of neuromyopathy.
    Xie F; Min S; Chen J; Yang J; Wang X
    J Neurochem; 2017 Oct; 143(2):225-235. PubMed ID: 28796387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response.
    Hung YL; Fang SH; Wang SC; Cheng WC; Liu PL; Su CC; Chen CS; Huang MY; Hua KF; Shen KH; Wang YT; Suzuki K; Li CY
    Sci Rep; 2017 Apr; 7():46299. PubMed ID: 28397806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.
    Lee W; Ku SK; Bae JS
    Toxicol Appl Pharmacol; 2017 Aug; 329():202-211. PubMed ID: 28610995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis.
    Anderson P; Souza-Moreira L; Morell M; Caro M; O'Valle F; Gonzalez-Rey E; Delgado M
    Gut; 2013 Aug; 62(8):1131-41. PubMed ID: 22637701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis.
    Delsesto D; Opal SM
    Contrib Microbiol; 2011; 17():137-156. PubMed ID: 21659751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical sepsis: dysregulation of immune function and therapeutic implications.
    Boontham P; Chandran P; Rowlands B; Eremin O
    Surgeon; 2003 Aug; 1(4):187-206. PubMed ID: 15570763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?
    Opal SM; Cohen J
    Crit Care Med; 1999 Aug; 27(8):1608-16. PubMed ID: 10470773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting STAT3: A crucial modulator of sepsis.
    Lei W; Liu D; Sun M; Lu C; Yang W; Wang C; Cheng Y; Zhang M; Shen M; Yang Z; Chen Y; Deng C; Yang Y
    J Cell Physiol; 2021 Nov; 236(11):7814-7831. PubMed ID: 33885157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astragaloside IV protects against polymicrobial sepsis through inhibiting inflammatory response and apoptosis of lymphocytes.
    Liu R; Jiang H; Tian Y; Zhao W; Wu X
    J Surg Res; 2016 Jan; 200(1):315-23. PubMed ID: 26375505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compensatory anti-inflammatory response syndrome.
    Adib-Conquy M; Cavaillon JM
    Thromb Haemost; 2009 Jan; 101(1):36-47. PubMed ID: 19132187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption.
    Wu X; Ren J; Chen G; Wu L; Song X; Li G; Deng Y; Wang G; Gu G; Li J
    Sci Rep; 2017 Jun; 7(1):4364. PubMed ID: 28663567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel synthetic dibenzocyclooctadiene lignan analog XLYF-104-6 attenuates lipopolysaccharide-induced inflammatory response in RAW264.7 macrophage cells and protects BALB/c mice from sepsis.
    Gu C; Yu FL; Yu L; He XY; Zhong D; He L; Lv L; Xie L; Liu S
    Eur J Pharmacol; 2014 Apr; 729():22-9. PubMed ID: 24462571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.